Original Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2013; 19(18): 2772-2780
Published online May 14, 2013. doi: 10.3748/wjg.v19.i18.2772
Figure 5
Figure 5 Overall 5-year survival rates as determined by the expression level of CAPN10 in esophageal squamous cell carcinoma patients. Low expression group of CAPN10 in ESCC patients showed a significantly lower 5-year survival rate than those of high expression group.